Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
life sciences
biotech
national blog main
boston blog main
detroit blog main
detroit top stories
healthcare
national top stories
wisconsin blog main
wisconsin top stories
4490 ventures
accomplice
accuray
advanced medical optics
alfalight
alirocumab
american family ventures
amgen
arvelle
atlas venture
baird capital
bioinnovation capital
biolabs
bms
boston
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
capital midwest fund
cardiac
cardiovascular
cause of death
cedar-sinai
chemotherapy
cholesterol
circulation
clean energy
clinical studies
daraprim
What
healthcare
4
×
drug
firm
fund
investment
life
sciences
amsterdam
bets
biotech
board
bristol
cholesterol
driving
drugs
european
expensive
faces
financial
focused
foe
going
good
hint
history
improved
industry
inhibitors
innovation
innovations
investors
known
largest
latest
launched
long
lowering
lsp
medical
milwaukee
Language
unset
4
×
Current search:
xconomy.com
×
healthcare
×
unset
×
@xconomy.com
4 years ago
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund
@xconomy.com
4 years ago
Venture Investors Bets on Healthcare, and Milwaukee, With $75M Fund
@xconomy.com
4 years ago
Drug Pricing: Innovation, Investment, and the Public Good
@xconomy.com
4 years ago
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.)
